Antioxidant potential of ethanolic extract of Canavalia species in high-fat diet and streptozotocin-induced diabetic rats

Kuttiappan, Anitha; Lakshmi, S.; Satyanarayana, SV Padi

doi:10.4103/pr.pr_46_19

Cited by 7 publications

(4 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Asian countries, on the other hand, have a more diverse landscape. India, which is renowned for having a thriving pharmaceutical markets having Herbal medicine that numerous conditions, like diabetes, asthma, eczema, premenstrual syndrome, rheumatoid arthritis, Antioxidant, cancer [36] [37]. It uses a semi-centralized system that combines strict requirements with quick review times.…”

Section: Discussionmentioning

confidence: 99%

Analysis of Regulatory Strategies for Generic Product Approval across Asian Nations

Nelavala

2024

Int. J.Exp. Biomed. Res.

View full text Add to dashboard Cite

The pharmaceutical industry is critical for providing accessible, affordable healthcare globally. This study compares regulatory strategies for generic drug approvals in Europe and Asia, focusing on India, China, and Japan. It analyzes legal frameworks, evaluation criteria, data requirements, and approval timelines, aiming to understand the impact on the efficiency of generic drug market entries in these regions. The research methodology includes reviewing regulatory guidelines, legislative documents, scholarly publications, and conducting interviews and surveys with industry experts. Preliminary findings reveal significant differences in the legal and procedural requirements across Asian nations, with variations in the emphasis on local clinical data and approval timelines. These disparities affect market accessibility, competition, and healthcare affordability. Insights from this study are vital for pharmaceutical companies navigating international markets and for policymakers aiming to harmonize and expedite approval processes, ultimately improving global access to cost-effective healthcare solutions.Top of Form

show abstract

Section: Discussionmentioning

confidence: 99%

Analysis of Regulatory Strategies for Generic Product Approval across Asian Nations

Nelavala

2024

Int. J.Exp. Biomed. Res.

View full text Add to dashboard Cite

show abstract

“…In conclusion, the development of innovative standards for drug registration based on international norms is a pivotal step forward for the Indian pharmaceutical sector and also Herbal medicine is used to treat numerous ailments, including diabetes, asthma, hepatoprotective, rheumatoid arthritis, cardio tonic, chronic tiredness, irritable bowel syndrome, and cancer [18] [19]. It not only enhances the competitiveness and credibility of the industry but also safeguards public health, promotes global harmonization, and fosters international collaboration.…”

Section: Discussionmentioning

confidence: 99%

Development of innovative standards for the registration of drugs in India based on International norms

Dhamotharan,

Vellore,

Nelavala

2024

Int. J. Clin. Pharm. Med. Sci.

View full text Add to dashboard Cite

This research endeavors to pioneer a paradigm shift in drug registration protocols within the Indian pharmaceutical sector, aligning them with internationally recognized norms. The study delves into the imperative need for harmonizing regulatory standards to ensure the safety, efficacy, and quality of pharmaceutical products entering the Indian market. By integrating key benchmarks from global authorities, this initiative aims to foster a robust and transparent registration process, ultimately bolstering consumer trust and industry competitiveness. The research methodology encompasses a comprehensive review of international regulatory frameworks, comparative analysis, stakeholder consultations, and case studies to propose a refined set of standards tailored to the Indian context. Additionally, this study addresses potential challenges and proposes strategies for effective implementation. Through this innovative approach, the research aspires to lay the foundation for a more dynamic and globally integrated pharmaceutical landscape in India, poised for sustained growth and excellence.

show abstract

“…Herbal medicine treats numerous conditions, like allergies, asthma, eczema, premenstrual syndrome, rheumatoid arthritis, fibromyalgia, migraine, menopausal symptoms, chronic fatigue, irritable bowel syndrome, and cancer, among others [19] [20]. Protecting public health and welfare by preventing and combatting the overuse and misuse of these substances is one of the main goals of the NDPS Act.…”

Section: Discussionmentioning

confidence: 99%

Deciphering the narcotic drugs and psychotropic substances act of 1985 and its enforcement guidelines in India

Jothieswari,

Bindu,

Nelavala

2023

Fut J. Pharm & H. Sci

View full text Add to dashboard Cite

This study explores the Narcotic Drugs and Psychotropic Substances Act of 1985 (NDPS Act) and its enforcement in South India. It provides a nuanced understanding of the Act's application through an analysis of legal provisions, case studies, and regional practices. The research focuses on regulatory frameworks, law enforcement strategies, and the societal impact of drug control policies in the southern states of India, highlighting the multifaceted nature of these policies. The findings emphasize the importance of context- specific approaches in drug regulation and enforcement. The NDPS Act, enacted by the Government of India, addresses the illicit trafficking and abuse of narcotic drugs and psychotropic substances. It regulates activities related to these substances, including production, manufacture, possession, sale, purchase, transport, warehousing, use, consumption, and inter-state and international trade. This comprehensive legislation plays a crucial role in shaping drug control strategies and has significant implications for both legal enforcement and social dynamics within the region.

show abstract

Antioxidant potential of ethanolic extract of Canavalia species in high-fat diet and streptozotocin-induced diabetic rats

Cited by 7 publications

References 22 publications

Analysis of Regulatory Strategies for Generic Product Approval across Asian Nations

Analysis of Regulatory Strategies for Generic Product Approval across Asian Nations

Development of innovative standards for the registration of drugs in India based on International norms

Deciphering the narcotic drugs and psychotropic substances act of 1985 and its enforcement guidelines in India

Contact Info

Product

Resources

About